Autolus Therapeutics (AUTL) Competitor Comparison
We are evaluating the key criteria listed to compare Autolus Therapeutics (AUTL) against its competitors in the Biotechnology industry.
Market Capitalization
102 / 368Gross Profits
248 / 278Total Revenue
200 / 300EBITDA
262 / 337Free Cashflow
298 / 352Quick Ratio
116 / 357Earnings per Share
144 / 359Dividend yield
0 / 6Total Cash
129 / 358Performance 3 years
159 / 368Performance 5 years
208 / 368Performance 10 years
232 / 368Linearity 3 years
96 / 368Linearity 5 years
160 / 368Linearity 10 years
200 / 368Total Rank
200 / 368Dividend Rank
51 / 368Valuation Rank
137 / 368Piotroski Rank
41 / 368Muliplier Rank
283 / 368Total Rank - AUTL ranking 200 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.